cmi_logo.png
[Latest] Global Carbonated Beverages Market Size/Share Worth USD 771.3 Billion by 2033 at a 5.60% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
May 17, 2024 03:30 ET | Custom Market Insights
Austin, TX, USA, May 17, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Carbonated Beverages Market Size, Trends and Insights By Product Type (Cola...
Global Post-consumer Recycled Plastics Market
Post-consumer Recycled Plastics Market Analysis Report 2024, By Source (Bottles, Non-bottle Rigid), By Type (PP, PS, PE, PVC, PET) and Region
May 16, 2024 10:40 ET | Research and Markets
Dublin, May 16, 2024 (GLOBE NEWSWIRE) -- The "Post-consumer Recycled Plastics Market Size, Share & Trends Analysis Report By Source (Bottles, Non-bottle Rigid), By Type (PP, PS, PE, PVC, PET),...
Global Pet Sitting Market
Pet Sitting Market Trends Analysis Report 2024-2030, Featuring A Place for Rover, Pets at Home, Wag! Group, PetBacker, Careguide, Fetch! Pet Care, Holidog, PetSmart, Dogtopia and Swifto
May 16, 2024 10:37 ET | Research and Markets
Dublin, May 16, 2024 (GLOBE NEWSWIRE) -- The "Pet Sitting Market Size, Share & Trends Analysis Report By Pet Type (Dogs, Cats), By Service Type (Care Visits, Drop-in Visits), By Region, And...
cmi_logo.png
[Latest] Global Sports and Energy Drinks Market Size/Share Worth USD 150.22 Billion by 2033 at a 7.48% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
May 14, 2024 05:30 ET | Custom Market Insights
Austin, TX, USA, May 14, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Sports and Energy Drinks Market Size, Trends and Insights By Product Type (Sports...
cmi_logo.png
[Latest] Global Cancer Supportive Care Drugs Market Size/Share Worth USD 32,783.2 Billion by 2033 at a 3.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
May 06, 2024 12:30 ET | Custom Market Insights
Austin, TX, USA, May 06, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Cancer Supportive Care Drugs Market Size, Trends and Insights By Drug Type...
Realtors®’ Charitabl
Realtors®’ Charitable Giving and Volunteering Increased Last Year
May 01, 2024 09:00 ET | National Association of Realtors®
WASHINGTON, May 01, 2024 (GLOBE NEWSWIRE) -- Key Highlights Nearly seven out of 10 (69%) Realtor® members at large volunteered monthly, typically spending eight hours volunteering each...
Figure 1*
Tiziana Life Sciences Reports Positive 3-Month Neuroimaging Scores in Multiple Sclerosis Patients Receiving Intranasal Foralumab
April 25, 2024 10:00 ET | Tiziana Life Sciences Ltd.
NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via...
tiziana-logo.png
Tiziana Life Sciences Announces FDA Allowance for Additional Twenty Patients to be Enrolled in the Intranasal Foralumab Multiple Sclerosis Expanded Access Program
April 23, 2024 07:00 ET | Tiziana Life Sciences Ltd.
NEW YORK, April 23, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via...
Remedium Healthcare Products
Remedium Healthcare Products Launches NuVeria Labs' Groundbreaking Sacral Silicone Dressing, Now Available for Purchase on Amazon Prime
April 19, 2024 19:44 ET | Remedium Healthcare Products
Remedium Healthcare Products announces the launch of NuVeria Labs' Sacral Silicone Dressing on Amazon, setting a new standard in accessible, advanced wound
tiziana-logo.png
Tiziana Life Sciences Announces Study Results from Intranasal Anti-CD3 Foralumab in Multiple Sclerosis Patients with PIRA Highlighted in Neurology Today®
April 19, 2024 07:00 ET | Tiziana Life Sciences Ltd.
- Intranasal foralumab attenuated microglial activation in patients with non-active secondary progressive multiple sclerosis and progression independent of relapse (PIRA) -- Data presented in a...